4//SEC Filing
Andrews Timothy K. 4
Accession 0001562180-19-003851
CIK 0001656328other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 1:42 PM ET
Size
7.8 KB
Accession
0001562180-19-003851
Insider Transaction Report
Form 4
Andrews Timothy K.
General Counsel & Secretary
Transactions
- Tax Payment
Common Stock
2019-07-02$0.76/sh−4,095$3,112→ 95,558 total
Holdings
- 15,000(indirect: See Footnote)
Common Stock
- 10,000(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Represents shares otherwise issuable to the Reporting Person that were withheld to satisfy the Issuer's tax withholding obligation upon settlement of restricted stock units.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.72 to $0.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes a total of 2,916 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.
- [F4]The shares are held by Steelhead Bioventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.
- [F5]The shares are held directly by the Andrews Living Trust (the "Trust"), of which the Reporting Person serves as co-trustee. The Reporting Person and members of his immediate family are beneficiaries of the Trust. The Reporting Person disclaims beneficial ownership of the shares of the Issuer's common stock held by the Trust except to the extent of his pecuniary interest therein.
Documents
Issuer
Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Entity typeother
Related Parties
1- filerCIK 0001711464
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 1:42 PM ET
- Size
- 7.8 KB